Jackson M Costa Selected Research

Diffuse Cutaneous Leishmaniasis

1/2020	Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis.
10/2017	Resolvin D1 drives establishment of Leishmania amazonensis infection.
2/2015	Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis.
7/2014	SOD1 plasma level as a biomarker for therapeutic failure in cutaneous leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jackson M Costa Research Topics

Disease

5	Cutaneous Leishmaniasis 01/2020 - 07/2011
4	Diffuse Cutaneous Leishmaniasis 01/2020 - 07/2014
3	Infections 10/2017 - 01/2006
2	Leishmaniasis 10/2017 - 01/2006
1	Mucocutaneous Leishmaniasis 04/2016
1	Schistosomiasis (Bilharziasis) 01/2016
1	Ulcer 07/2011
1	Disease Progression 07/2011
1	Sepsis (Septicemia) 01/2006
1	Asthma (Bronchial Asthma) 01/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2006
1	Neoplasms (Cancer) 01/2006

Drug/Important Bio-Agent (IBA)

2	PolyaminesIBA 01/2020 - 02/2015
2	EicosanoidsIBA 10/2017 - 04/2016
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 07/2014
2	Praziquantel (Biltricide)FDA Link 01/2016 - 08/2011
1	Amino Acids FDA Link 01/2020
1	resolvin D1IBA 10/2017
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 02/2015
1	ArginaseIBA 02/2015
1	Dinoprostone (PGE2)FDA Link 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2015
1	Superoxide Dismutase-1IBA 07/2014
1	Pharmaceutical PreparationsIBA 07/2014
1	AntimonyIBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011
1	Interferon-gamma (Interferon, gamma)IBA 07/2011
1	AntigensIBA 07/2011
1	CytokinesIBA 07/2011
1	Tumor Necrosis Factor InhibitorsIBA 07/2011
1	Fc Receptors (Fc Receptor)IBA 01/2006
1	Immunoglobulin G (IgG)IBA 01/2006

Therapy/Procedure

2	Therapeutics 10/2017 - 07/2011